Maxim Group Upgrades BioLineRx (BLRX) to Buy
Tweet Send to a Friend
Maxim Group upgraded BioLineRx (NASDAQ: BLRX) from Hold to Buy with a price target of $3.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE